Immunotherapy

AFCR-Funded Innovative Immunotherapy Received Clinical Trial Approval!

Since 2020 AFCR has funded a novel multi-targeting immunotherapeutic platform that we envisioned could provide a safe and effective treatment for gastrointestinal (GI) cancers. Today I am excited to share with you the program’s recent great progress!  With your previous support and funding, the drug indicated for the potential treatment…...

Read more

Novel Immunotherapeutic Oral Cancer Treatment

Did you know 66% of the world’s oral cancer diagnoses occur in Asia only 50% of people diagnosed will survive within 5 years the highest rates of oral cancer are found in Southeast Asia men are 75% more likely to be diagnosed with oral cancer than women in Asia It…...

Read more

New Immunotherapy Treatment Removes All Tumors In Woman With Advanced Metastatic Breast Cancer

Research published today in Nature Medicine by scientists at the National Cancer Institute (NCI) has described a new immunotherapy approach, which led to a complete disappearance of tumors in a woman with advanced metastatic breast cancer who only had months to live. The findings show how naturally-occurring tumor infiltrating lymphocytes…...

Read more

News digest – obesity and cancer, bacteria on skin, new immunotherapy targets and… vaping safety?

Anne Li                                                                                     March 11th, 2018   This week, Cancer…...

Read more

Molecular ‘magnets’ could improve cancer immunotherapy

Anne Li                                                                                     Feburary 24th, 2018   Chemicals that attract…...

Read more

Viruses may boost immunotherapy in brain and breast cancer

Anne Li                       1/5/18   Infecting tumours with viruses may boost the success of immunotherapy for brain and breast cancers, according to two new studies. Immunotherapy treatments can trigger impressive responses in patients with a handful of advanced cancers. But success…...

Read more

New technique could reveal immunotherapy targets, study finds

Anne Li Researchers at the Stanford University School of Medicine and their colleagues have developed a way to pinpoint potential targets for cancer therapies that rely on the body’s immune system. Those targets are molecules called antigens, which appear on the surface of tumor cells and other malignant or damaged…...

Read more

Gut bacteria may influence response to cancer immunotherapy

Anne Li                                                                                     November 3rd, 2017   The type of…...

Read more

Computer programme could predict if immunotherapy will work

Anne Li                                                                                     November 3rd, 2017   Combining information from…...

Read more

New markers could identify patients most at risk of brain damage from CAR T cell immunotherapy

Anne Li                                                                                     October 28th, 2017   Blood cancer patients…...

Read more